Biotech | December 17, 2021
New data suggests Covaxin generates robust memory to Covid-19 and variants six months after vaccination
Effectiveness of Covaxin against the Omicron variant is currently being studied
Effectiveness of Covaxin against the Omicron variant is currently being studied
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
The company will provide the technical and financial resources to support the study
This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
Subscribe To Our Newsletter & Stay Updated
